寡单核细胞型与典型慢性粒单核细胞白血病特征相似
研究比较40例寡单核细胞型慢性粒单核细胞白血病(OM-CMML)与56例典型CMML,发现两者临床、形态学、细胞遗传学、分子及免疫表型相似,仅RAS通路突变率较低。MO1>94%方法预测CMML诊断敏感度90.7%、特异度92.2%。结果支持将OM-CMML视为CMML的独特亚型。
要点
- OM-CMML与典型CMML临床、形态学及细胞遗传学特征相似。
- OM-CMML分子谱类似CMML,但RAS通路突变率较低,仅CBL突变频率显著更低。
- 外周血单核细胞MO1>94%预测CMML诊断敏感度90.7%、特异度92.2%。
核心结论
- OM-CMML与典型CMML在临床、基因组及免疫表型上相似,支持将其视为CMML的独特亚型。
研究设计与样本
- 研究分析40例OM-CMML与56例典型CMML的临床病理特征,并比较免疫表型与分子数据。
- 免疫表型预测准确性在233例患者中评估,包括39例OM-CMML、54例CMML、23例MDS、15例伴单核细胞增多的骨髓增殖性肿瘤及102例反应性单核细胞增多。
主要发现
- OM-CMML与典型CMML的临床、形态学及细胞遗传学特征相似。
- OM-CMML分子谱类似CMML,但RAS通路突变比例较低,仅CBL突变频率显著更低。
- OM-CMML免疫表型(MO1>94%及CD56和/或CD2阳性)与典型CMML相似。
- MO1>94%方法预测CMML诊断敏感度90.7%、特异度92.2%;将OM-CMML视为CMML亚型时敏感度84.9%、特异度92.1%。
关键数值与推荐
- OM-CMML定义为MDS或MDS/MPN不能分类伴相对单核细胞增多(单核细胞≥10%)且单核细胞计数0.5至<1×10^9/L。
- MO1>94%预测CMML诊断敏感度90.7%、特异度92.2%。
- 将OM-CMML视为CMML亚型时,MO1>94%方法敏感度84.9%、特异度92.1%。
临床怎么用
- 对单核细胞0.5至<1×10^9/L且相对单核细胞增多的患者,应评估是否符合OM-CMML。
- 外周血单核细胞MO1>94%可用于辅助CMML诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oligomonocytic chronic myelomonocytic leukemia (OM-CMML) is defined as those myelodysplastic syndromes (MDSs) or myelodysplastic/myeloproliferative neoplasms, unclassifiable with relative monocytosis (≥10% monocytes) and a monocyte count of 0.5 to <1 × 109/L. These patients show clinical and genomic features similar to those of overt chronic myelomonocytic leukemia (CMML), although most of them are currently categorized as MDS, according to the World Health Organization 2017 classification. We analyzed the clinicopathologic features of 40 patients with OM-CMML with well-annotated immunophenotypic and molecular data and compared them to those of 56 patients with overt CMML. We found similar clinical, morphological, and cytogenetic features. In addition, OM-CMML mirrored the well-known complex molecular profile of CMML, except for the presence of a lower percentage of RAS pathway mutations. In this regard, of the different genes assessed, only CBL was found to be mutated at a significantly lower frequency. Likewise, the OM-CMML immunophenotypic profile, assessed by the presence of >94% classical monocytes (MO1s) and CD56 and/or CD2 positivity in peripheral blood monocytes, was similar to overt CMML. The MO1 percentage >94% method showed high accuracy for predicting CMML diagnosis (sensitivity, 90.7%; specificity, 92.2%), even when considering OM-CMML as a subtype of CMML (sensitivity, 84.9%; specificity, 92.1%) in our series of 233 patients (39 OM-CMML, 54 CMML, 23 MDS, and 15 myeloproliferative neoplasms with monocytosis and 102 reactive monocytosis). These results support the consideration of OM-CMML as a distinctive subtype of CMML.
引用
- Calvo X, Garcia-Gisbert N, Parraga I, et al. Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features. Blood Adv. 2020. PMID: 33108455. doi:10.1182/bloodadvances.2020002206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。